Loading provider…
Loading provider…
Allergy Physician in Layton, UT
NPI: 1346324761Primary Practice Location
HOLY CROSS HOSPITAL-DAVIS
1600 W Antelope Dr, Layton, UT
Primary Employer
Metrodora Clinic, PLLC
metrodora.co
HQ Phone
Get M.D. Douglas's Phone Numberphone_androidMobile
Get M.D. Douglas's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardNE State Medical License
UT State Medical License
AZ State Medical License
2023 - 2026
UT State Medical License
2008 - 2026
MT State Medical License
2024 - 2026
MI State Medical License
2023 - 2026
MD State Medical License
2023 - 2026
IL State Medical License
2023 - 2026
GA State Medical License
2023 - 2026
ID State Medical License
2013 - 2025
MN State Medical License
2023 - 2025
CO State Medical License
2023 - 2025
ND State Medical License
2024 - 2025
OH State Medical License
2023 - 2025
TN State Medical License
2024 - 2025
AL State Medical License
2023 - 2025
WA State Medical License
2023 - 2025
WI State Medical License
2023 - 2025
TX State Medical License
2023 - 2024
OR State Medical License
2014 - 2019

American Board of Allergy and Immunology
Allergy & Immunology

National Board of Physicians and Surgeons
Allergy and Immunology

National Board of Physicians and Surgeons
Internal Medicine
Penn State College of Medicine
med.psu.edu
Medical School
Until 2003
Creighton University
Fellowship • Allergy and Immunology
2006 - 2008
Creighton University School of Medicine (Omaha)
Residency • Internal Medicine
2003 - 2006
Authors: Donald Levy, Jonathan Bernstein, Douglas Jones, William Lumry, Raffi Tachdjian, Jonathan Bernstein
Journal: Allergy Asthma Proc
Age-Related Food Aversion and Anxiety Represent Primary Patient Barriers to Food Oral Immunotherapy.
Authors: Douglas Jones, Jeffrey Factor, Philippe Begin, Richard Wasserman
Journal: J Allergy Clin Immunol Pract
Publication Date: 2024-03-14
Lead Sponsor: Takeda
Collaborators: Takeda Development Center Americas, Inc.
Intervention / Treatment: OTHER: Placebo, DRUG: Lanadelumab